Barclays Initiates Intermolecular at Equal-weight
Barclays Capital has initiated coverage on Intermolecular (NASDAQ: IMI) with an Equal-weight rating.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Barclays CapitalInitiation Pre-Market Outlook Analyst Ratings